Cargando…

Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales:	Ogawa, Ayaka, Yoshimura, Michio, Nakamura, Mitsuhiro, Adachi, Takanori, Iwai, Takahiro, Ashida, Ryo, Mizowaki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463611/ https://www.ncbi.nlm.nih.gov/pubmed/37612744 http://dx.doi.org/10.1186/s13014-023-02321-5

Ejemplares similares

Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
por: Ogawa, Ayaka, et al.
Publicado: (2023)

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
por: Iwai, Takahiro, et al.
Publicado: (2020)

Assessing target localization accuracy across different soft-tissue matching protocols using end-exhalation breath-hold cone-beam computed tomography in patients with pancreatic cancer
por: Sasaki, Makoto, et al.
Publicado: (2023)

Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning study
por: Ashida, Ryo, et al.
Publicado: (2020)

Potential utility of cone‐beam CT‐guided adaptive radiotherapy under end‐exhalation breath‐hold conditions for pancreatic cancer
por: Ogawa, Ayaka, et al.
Publicado: (2022)

Positional repeatability and variation in internal and external markers during volumetric-modulated arc therapy under end-exhalation breath-hold conditions for pancreatic cancer patients
por: Sasaki, Makoto, et al.
Publicado: (2020)

Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study)
por: Mitsuyoshi, Takamasa, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
por: Sugiura, Teiichi, et al.
Publicado: (2020)

Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
por: Lin, Ting-Chun, et al.
Publicado: (2020)

Appropriate margin for planning target volume for breast radiotherapy during deep inspiration breath-hold by variance component analysis
por: Ono, Yuka, et al.
Publicado: (2021)

Reducing variability among treatment machines using knowledge‐based planning for head and neck, pancreatic, and rectal cancer
por: Hirashima, Hideaki, et al.
Publicado: (2021)

Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study
por: Masui, Toshihiko, et al.
Publicado: (2023)

Beyond the heart in hypofractionated radiotherapy and in the transition from 3D to IMRT/VMAT
por: Mondragon, Lorena Lio, et al.
Publicado: (2023)

Vulnerabilities of radiomic features to respiratory motion on four‐dimensional computed tomography‐based average intensity projection images: A phantom study
por: Adachi, Takanori, et al.
Publicado: (2022)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy
por: Rudat, Volker, et al.
Publicado: (2016)

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer
por: Nakamura, Kiyonao, et al.
Publicado: (2018)

A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy
por: Kawamura, Mitsue, et al.
Publicado: (2019)

Analyses of integrated EPID images for on‐treatment quality assurance to account for interfractional variations in volumetric modulated arc therapy
por: Matsushita, Norimasa, et al.
Publicado: (2020)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
por: Wada, Ryo, et al.
Publicado: (2005)

The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation
por: Ono, Yuka, et al.
Publicado: (2019)

Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
por: Dapper, Hendrik, et al.
Publicado: (2018)

Development of independent dose verification plugin using Eclipse scripting API for brachytherapy
por: Zhou, Dejun, et al.
Publicado: (2022)

Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT
por: Mukumoto, Nobutaka, et al.
Publicado: (2016)

Image quality evaluation of intra‐irradiation cone‐beam computed tomography acquired during one‐ and two‐arc prostate volumetric‐modulated arc therapy delivery: A phantom study
por: Iramina, Hiraku, et al.
Publicado: (2020)

A margin-based analysis of the dosimetric impact of motion on step-and-shoot IMRT lung plans
por: Waghorn, Benjamin J, et al.
Publicado: (2014)

DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer
por: Münch, S, et al.
Publicado: (2017)

Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study
por: Wu, Xin, et al.
Publicado: (2016)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19
por: Spiers, H.V., et al.
Publicado: (2022)

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)

Pharmacological inhibition of sodium-calcium exchange activates NADPH oxidase and induces infection-independent NETotic cell death
por: Inoue, Minoru, et al.
Publicado: (2021)

Curtailing patient-specific IMRT QA procedures from 2D dose error distribution
por: Kurosu, Keita, et al.
Publicado: (2016)

Determination of optimal PTV margin for patients receiving CBCT‐guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins
por: Gill, Sukhdeep K., et al.
Publicado: (2015)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
por: de Siqueira, Gabriela S.M., et al.
Publicado: (2022)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Development of AI-driven prediction models to realize real-time tumor tracking during radiotherapy
por: Zhou, Dejun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqkn5sq9r6nmp29nsfc6m8u512